Fog Pharmaceuticals

fogpharma.com

FogPharma, now known as Parabilis Medicines, is advancing a new category of ultra-tunable peptide therapeutics aimed at fundamentally changing treatment possibilities for cancer and other severe diseases. The company leverages its Helicon™ peptide platform to create extraordinary medicines that have the potential for life-changing impacts on patients. With a mission-driven approach, FogPharma is focused on developing innovative therapies that address critical medical needs, supported by a unique syndicate of private and institutional investors. Their commitment to tackling previously unsolvable problems positions them as a pioneering force in the drug discovery landscape.